Policy Options to Lower Prescription Drug Prices in the United States

被引：0
|
作者：
Alexander, G. Caleb [1 ,2 ,3 ]
Ballreich, Jeromie [6 ]
Socal, Mariana P. [1 ]
Karmarkar, Taruja [1 ,4 ]
Trujillo, Antonio [5 ]
Green, Jeremy [1 ]
Sharfstein, Joshua [6 ]
Anderson, Gerard [4 ]
机构：
[1] Johns Hopkins Univ, Ctr Drug Safety & Effectiveness, Baltimore, MD USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Epidemiol, Baltimore, MD USA
[3] Johns Hopkins Med, Gen Internal Med, Baltimore, MD USA
[4] Johns Hopkins Bloomberg Sch Publ Hlth, Int Hlth, Baltimore, MD USA
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Off Dean, Baltimore, MD USA
[6] Johns Hopkins Univ, Hlth Econ, Baltimore, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2016年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1075
引用
收藏
页码：625 / 626
页数：2
相关论文
共 50 条
  • [41] Drug Shortages in the United States Are Some Prices Too Low?
    Hernandez, Inmaculada
    Hershey, Tina Batra
    Donohue, Julie M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (09): : 819 - 820
  • [42] HEALTH-POLICY IN THE UNITED-STATES - ISSUES AND OPTIONS
    BROWN, LD
    BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 1987, 63 (05) : 427 - 479
  • [43] CENTRAL AMERICAN REALITIES - UNITED-STATES-POLICY OPTIONS
    BARNES, M
    JOHNSTONE, LC
    BURNS, EB
    WIARDA, H
    CROSSETTE, B
    BECKLUND, L
    DISKIN, M
    NUCCIO, RA
    APPELBAUM, R
    GONZALEZ, E
    PERRY, W
    WESSON, R
    WEINSTEIN, A
    SERESERES, CD
    CENTER MAGAZINE, 1984, 17 (04): : 15 - +
  • [44] Lower drug prices?
    Mitka, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (02): : 152 - 152
  • [45] Public/Private partnerships for prescription drug coverage: Policy formulation and outcomes in Quebec's universal drug insurance program, with comparisons to the medicare prescription drug program in the United States
    Pomey, Marie-Pascale
    Forest, Pierre-Gerlier
    Palley, Howard A.
    Martin, Elisabeth
    MILBANK QUARTERLY, 2007, 85 (03): : 469 - 498
  • [46] Prescription Drug Monitoring Programs and Prescription Opioid-Related Outcomes in the United States
    Puac-Polanco, Victor
    Chihuri, Stanford
    Fink, David S.
    Cerda, Magdalena
    Keyes, Katherine M.
    Li, Guohua
    EPIDEMIOLOGIC REVIEWS, 2020, 42 (01) : 134 - 153
  • [47] Use of Public Research and Manufacturing Enterprises to Lower Prescription Drug Prices and Increase Innovation
    Moss, Alex
    Brown, Dana
    Tu, S. Sean
    JOURNAL OF LAW MEDICINE & ETHICS, 2024, 52 (03): : 750 - 754
  • [48] CAAP Rule and Prescription Drug Prices
    Walsh, Bryan S.
    Kesselheim, Aaron S.
    AMERICAN JOURNAL OF MANAGED CARE, 2021, 27 (08): : 312 - 314
  • [49] DOMESTIC AND FOREIGN PRESCRIPTION DRUG PRICES
    JACOBY, EM
    HEFNER, DL
    SOCIAL SECURITY BULLETIN, 1971, 34 (05) : 15 - 22
  • [50] PUBLIC POLICY CONSIDERATIONS IN PRICING OF PRESCRIPTION DRUGS IN UNITED-STATES
    RUCKER, TD
    INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1974, 4 (01): : 171 - 179
12345